- €14.26bn
- €21.47bn
- €39.46bn
- 71
- 96
- 94
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 23,461 | 16,550 | 35,555 | 62,298 | 39,463 |
Cost of Revenue | |||||
Gross Profit | 8,158 | 5,060 | 11,653 | 18,458 | 11,237 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 20,264 | 15,537 | 31,091 | 51,925 | 34,564 |
Operating Profit | 3,197 | 1,013 | 4,464 | 10,373 | 4,899 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,453 | 875 | 4,870 | 10,765 | 4,604 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,147 | 1,478 | 2,804 | 5,175 | 1,917 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,754 | 1,342 | 2,187 | 3,705 | 1,551 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,678 | 1,258 | 2,093 | 3,634 | 1,480 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.69 | 6.73 | 11 | 12.6 | 5.53 |
Dividends per Share |